Ji Won Woo

Ji Won Woo

Auto-generated profile, based on publicly available information

Ji Won Woo

Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2020 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
PDF file
SASoomin Ahn
Soomin Ahn
JWJi Won Woo
Ji Won Woo
KLKyoungyul Lee
Kyoungyul Lee
SPSo-Yeon Park
So-Yeon Park
Human epidermal growth factor receptor 2 (HER2) protein overexpression and/or HER2 gene amplification is found in about 20% of invasive breast cancers. It is a sole predictive marker for treatment benefits from HER2 targeted therapy and thus, HER2 testing is a routine practice for newly diagnosed breast cancer in pathology. Currently, HER2 immunohistochemistry (IHC) is used for a screening test, and in situ hybridization is used as a confirmation test for HER2 IHC equivocal cases. Since the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guidelines on HER2 testing was first released in 2007, it has been updated to provide clear instructions for HER2 testing and accurate determination of HER2 status in breast cancer. During HER2 interpretation, some pitfalls such as intratumoral HER2 heterogeneity and increase in chromosome enumeration probe 17 signals may lead to inaccurate assessment of HER2 status. Moreover, HER2 status can be altered after neoadjuvant chemotherapy or during metastatic progression, due to biologic or methodologic issues. This review addresses recent updates of ASCO/CAP guidelines and factors complicating in the interpretation of HER2 status in breast cancers.


28 June 2022 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
KSKoung Jin Suh
Koung Jin Suh
SKSe Hyun Kim
Se Hyun Kim
YKYu Jung Kim
Yu Jung Kim
HSHeechul Shin
Heechul Shin
EKEunyoung Kang
Eunyoung Kang
JKJee Hyun Kim
Jee Hyun Kim
Suh KJ, et al. J Breast Cancer. 2022 Jun;25:e30. https://doi.org/10.4048/jbc.2022.25.e30

1 January 2019 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
JWJi Won Woo
Ji Won Woo
YCYul Ri Chung
Yul Ri Chung
SASoomin Ahn
Soomin Ahn
EKEunyoung Kang
Eunyoung Kang
EKEun-Kyu Kim
Eun-Kyu Kim
SPSo-Yeon Park
So-Yeon Park
Woo JW, et al. J Breast Cancer. 2019 Jul;22:e38. https://doi.org/10.4048/jbc.2019.22.e38

1 January 2021 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
SASoomin Ahn
Soomin Ahn
JWJi Won Woo
Ji Won Woo
HKHyojin Kim
Hyojin Kim
ECEun Yoon Cho
Eun Yoon Cho
AKAhrong Kim
Ahrong Kim
SPSo-Yeon Park
So-Yeon Park
Ahn S, et al. J Breast Cancer. 2021 Jun;24(3):266-279. https://doi.org/10.4048/jbc.2021.24.e29

5 November 2022 in Breast Cancer
Verified
Journal Article
Open access
PDF file
JWJi Won Woo
Ji Won Woo
HCHye Yeon Choi
Hye Yeon Choi
MKMilim Kim
Milim Kim
YCYul Ri Chung
Yul Ri Chung
SPSo-Yeon Park
So-Yeon Park